Diagnosis and management of insulinoma

doi:10.3748/wjg.v19.i6.829

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (28186)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

2467

HTML

25025

Figures (1-6)

483

Tables (1-1)

211

Sum=28186

Feb 14, 2013 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (290)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Feb 14, 2013; 19(6): 829-837
Published online Feb 14, 2013. doi: 10.3748/wjg.v19.i6.829

Full Size Figure Download Figure

Figure 6 In patients who have unresectable or uncontrollable malignant insulinomas of the pancreas, several strategies need to be considered to both control hypoglycemic episodes and improve quality of life, including administration of ocreotide and continuous glucose monitoring. RFA: Radiofrequency ablation; LN: Lymph node.

Citation: Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K. Diagnosis and management of insulinoma. World J Gastroenterol 2013; 19(6): 829-837
URL: https://www.wjgnet.com/1007-9327/full/v19/i6/829.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i6.829